Page last updated: 2024-10-20

pyrazinamide and Allergic Encephalomyelitis

pyrazinamide has been researched along with Allergic Encephalomyelitis in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jenh, CH1
Cox, MA1
Cui, L1
Reich, EP1
Sullivan, L1
Chen, SC1
Kinsley, D1
Qian, S1
Kim, SH1
Rosenblum, S1
Kozlowski, J1
Fine, JS1
Zavodny, PJ1
Lundell, D1

Other Studies

1 other study available for pyrazinamide and Allergic Encephalomyelitis

ArticleYear
A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection.
    BMC immunology, 2012, Jan-10, Volume: 13

    Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoimmune Diseases; Chemotaxis, Leukocyte;

2012